» Articles » PMID: 11867408

The Laryngeal Mask Airway ProSeal(TM) As a Temporary Ventilatory Device in Grossly and Morbidly Obese Patients Before Laryngoscope-guided Tracheal Intubation

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2002 Feb 28
PMID 11867408
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: We determined the efficacy of the laryngeal mask airway ProSeal(TM) (PLMA) as a temporary ventilatory device in morbidly obese patients before laryngoscope-guided tracheal intubation. Sixty patients (body mass index 35--60 kg/m(2)) scheduled for elective surgery, who preferred airway management under general anesthesia, were studied. The induction of anesthesia was with midazolam/fentanyl/propofol and maintenance was with sevoflurane 1%--3% in oxygen 100%. The PLMA was inserted and an effective airway established. Rocuronium was given IV for paralysis. Oropharyngeal leak pressure, ease of gastric tube placement, residual gastric volume, fiberoptic position of the airway/drainage tube, and ease of ventilation at a tidal volume of 8 mL/kg was determined. The PLMA was then removed and laryngoscope-guided tracheal intubation attempted. The number of insertion/intubation attempts (maximum two each) and time taken to establish an effective airway with each device were recorded. An effective airway was obtained at the first insertion attempt in 90% of patients (54/60) and at the second attempt in 10% (6/60). The time taken to provide an effective airway was 15 plus minus 7 s (7--42 s). Oropharyngeal leak pressure was 32 plus minus 8 cm H(2)O (12--40 cm H(2)O). The residual gastric volume was 36 plus minus 46 mL (0--240 mL). Positive pressure ventilation without air leaks was possible in 95% of patients (57/60). The vocal cords were seen from the airway tube in 75% of patients (45/60), but the esophagus was not seen. The fiberoptic view from the drainage tube revealed mucosa in 93% of patients (56/60) and an open upper esophageal sphincter in 7% (4/60). Tracheal intubation was successful at the first attempt in 90% of patients (54/60), at the second attempt in 7% (4/60), and failed in 3% (2/60). In these latter two patients, the PLMA was reinserted and surgery performed uneventfully with the PLMA. The time taken to tracheally intubate the patient was 13 plus minus 10 s (8--51 s). There were no episodes of hypoxia (SpO(2) <90%) or other adverse events. There were no differences in insertion success rate, or the time to successful insertion between the PLMA and laryngoscope-guided intubation. We conclude that the PLMA is an effective temporary ventilatory device in grossly or morbidly obese patients before laryngoscope-guided tracheal intubation.

Implications: The laryngeal mask airway ProSeal(TM) is an effective temporary ventilatory device in grossly and morbidly obese patients before laryngoscope-guided tracheal intubation.

Citing Articles

COVID-19 respiratory support in the emergency department setting.

Montrief T, Ramzy M, Long B, Gottlieb M, Hercz D Am J Emerg Med. 2020; 38(10):2160-2168.

PMID: 33046288 PMC: 7413866. DOI: 10.1016/j.ajem.2020.08.001.


Clinical performance of the LMA Protector™ airway in moderately obese patients.

Shariffuddin I, Chaw S, Ng L, Lim C, Zainal Abidin M, Wan Zakaria W BMC Anesthesiol. 2020; 20(1):184.

PMID: 32736516 PMC: 7393866. DOI: 10.1186/s12871-020-01100-z.


Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of....

Cook T, El-Boghdadly K, McGuire B, McNarry A, Patel A, Higgs A Anaesthesia. 2020; 75(6):785-799.

PMID: 32221970 PMC: 7383579. DOI: 10.1111/anae.15054.


A feasibility study of jaw thrust as an indicator assessing adequate depth of anesthesia for insertion of supraglottic airway device in morbidly obese patients.

Wan L, Shao L, Liu Y, Wang H, Xue F, Tian M Chin Med J (Engl). 2019; 132(18):2185-2191.

PMID: 31425359 PMC: 6797154. DOI: 10.1097/CM9.0000000000000403.


Dexmedetomidine reduces sevoflurane EC for supraglottic airway device insertion in spontaneously breathing morbidly obese patients.

Wan L, Shao L, Liu Y, Wang H, Xue F, Tian M Ther Clin Risk Manag. 2019; 15:627-635.

PMID: 31118650 PMC: 6504637. DOI: 10.2147/TCRM.S199440.